Lyra Health

Lyra Health is a digital mental health company headquartered in Burlingame, California, that delivers employer-sponsored mental health benefits through a tech-enabled care platform. Their flagship product connects employees with a curated network of evidence-based therapists, coaches, and psychiatrists via a digital marketplace designed for seamless access and care matching. The Lyra Care model integrates video therapy sessions, self-guided digital programs, and medication management into a unified continuum of care that addresses the full spectrum of mental health needs. By combining clinical rigor with consumer-grade technology, Lyra enables personalized mental health support at enterprise scale.

Lyra Health has established itself as one of the leading players in the employer mental health benefits market, counting numerous Fortune 500 companies among its clients and serving millions of covered lives globally. The company has raised over $235 million in a Series F funding round, reflecting strong investor confidence in its growth trajectory and care model. Lyra has consistently emphasized outcomes-based care, publishing clinical data demonstrating measurable improvements in depression and anxiety symptoms among its members. These milestones have positioned Lyra as a benchmark for quality and accountability in the rapidly expanding mental health benefits sector.

Lyra Health matters to the broader neurotechnology and mental health tech industry because it represents a scalable, data-driven approach to closing the global mental health treatment gap. By embedding clinical intelligence and outcomes measurement into a digital platform, Lyra demonstrates how technology can systematically improve access to and quality of mental healthcare. Their model provides a commercial blueprint for translating neuroscience and behavioral health research into real-world, population-level interventions. As the line between digital therapeutics, mental health platforms, and neurotechnology continues to blur, Lyra occupies a critical position at the intersection of clinical credibility and technological innovation.